SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $312,273 | -1.5% | 89,992 | +32.0% | 0.00% | – |
| Q2 2023 | $317,061 | -78.2% | 68,185 | -78.4% | 0.00% | – |
| Q1 2023 | $1,456,672 | +23.8% | 315,297 | +116.6% | 0.00% | – |
| Q4 2022 | $1,176,367 | +386.1% | 145,590 | +233.1% | 0.00% | – |
| Q3 2022 | $242,000 | +120.0% | 43,712 | +106.5% | 0.00% | – |
| Q2 2022 | $110,000 | -95.0% | 21,165 | -92.1% | 0.00% | – |
| Q1 2022 | $2,197,000 | +26.8% | 267,239 | +129.5% | 0.00% | – |
| Q4 2021 | $1,733,000 | +153.4% | 116,430 | +221.5% | 0.00% | – |
| Q3 2021 | $684,000 | +5.4% | 36,213 | +3.6% | 0.00% | – |
| Q2 2021 | $649,000 | +19.1% | 34,941 | +46.0% | 0.00% | – |
| Q1 2021 | $545,000 | +533.7% | 23,936 | +505.2% | 0.00% | – |
| Q4 2020 | $86,000 | -73.9% | 3,955 | -88.0% | 0.00% | – |
| Q3 2020 | $330,000 | +71.0% | 32,901 | +32.6% | 0.00% | – |
| Q2 2020 | $193,000 | -12.3% | 24,810 | +15.1% | 0.00% | – |
| Q1 2020 | $220,000 | -27.2% | 21,563 | -21.4% | 0.00% | – |
| Q4 2019 | $302,000 | +45.9% | 27,424 | +20.1% | 0.00% | – |
| Q3 2019 | $207,000 | +21.1% | 22,839 | +52.0% | 0.00% | – |
| Q2 2019 | $171,000 | +48.7% | 15,030 | +47.8% | 0.00% | – |
| Q1 2019 | $115,000 | +400.0% | 10,166 | +285.2% | 0.00% | – |
| Q4 2018 | $23,000 | – | 2,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |